Merck advises against changing Gardasil's approved dosing regimen despite studies suggesting single-dose efficacy. Read more ...

Merck offers a low 8.5x PE, a 4.3% yield, a robust drug pipeline, and resilient growth despite Gardasil headwinds and tariff ...